Fluocinonide, USP, 0
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- Agency
- FDA Drug
- Recall date
- Mar 25, 2026
- Status
- Ongoing
- Company
- SUN PHARMACEUTICAL INDUSTRIES INC
1. What product was recalled?
Fluocinonide, USP, 0
Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-2.
Quantity: 41,712 30g tubes
Code or lot text: Lot# AD76251, Exp Date: 6/30/2026.
- LOT
- Exp Date: 6/30/2026.
- LOT
- Lot# AD76251
- NDC
- 51672-1386
- NDC
- 51672-1386-1
- NDC
- 51672-1386-2
- NDC
- 51672-1386-3
- NDC
- 51672-1386-4
- RECALL-NUMBER
- D-0476-2026
Fluocinonide, USP, 0
Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-3.
Quantity: 2,640 60g tubes
Code or lot text: Lot# AD76250, Exp Date: 6/30/2026.
- LOT
- Exp Date: 6/30/2026.
- LOT
- Lot# AD76250
- NDC
- 51672-1386
- NDC
- 51672-1386-1
- NDC
- 51672-1386-2
- NDC
- 51672-1386-3
- NDC
- 51672-1386-4
- RECALL-NUMBER
- D-0477-2026
Fluocinonide, USP, 0
Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-1
Quantity: 24,672 15 g tubes
Code or lot text: Lot# AD76252, Exp Date: 6/30/2026.
- LOT
- Exp Date: 6/30/2026.
- LOT
- Lot# AD76252
- NDC
- 51672-1386
- NDC
- 51672-1386-1
- NDC
- 51672-1386-2
- NDC
- 51672-1386-3
- NDC
- 51672-1386-4
- RECALL-NUMBER
- D-0475-2026
2. Is my exact product affected?
Compare every printed identifier. A matching value can indicate that your product is included.
3. What is the hazard?
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
4. What should I do now?
Follow the FDA recall notice and contact the recalling company for current instructions.
5. Where was it sold or distributed?
Nationwide
6. Were injuries or illnesses reported?
No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.
7. What remedy is available?
Follow the FDA recall notice and contact the recalling company for current instructions.
8. Is the recall active or closed?
The source status is Ongoing. Recall Index urgency is elevated, which is a separate deterministic site label.
9. When was the information checked?
Last checked .
- updated
- created
10. Where is the official source?
Open the official FDA Drug source
Recall Index normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.